Abstract Cannabis sativa, a versatile plant with numerous varieties, holds promising potential for a wide range of biological activity. As…
Abstract Cannabidiol (CBD), the main non-psychoactive component of Cannabis sativa L., is widely used in therapy for the treatment of…
Abstract Synthetic cannabinoid receptor agonists (SCRAs) have become a wide group of new psychoactive substances since the 2010s. For the…
Abstract The second part of this paper builds upon and expands the epigenomic-aging perspective presented in Part 1 to describe…
Abstract Cannabis legalization continues to progress in the USA for medical and recreational purposes. G protein-coupled receptor 55 (GPR55) is…
Abstract Cannabidiol (CBD) is a promising drug candidate with pleiotropic pharmacological activity, whose low aqueous solubility and unfavorable pharmacokinetics have…
Abstract The proportion of older adults using medical cannabis is rising. Therefore, we aimed to assess the effects of herbal…
Abstract Alzheimer’s disease (AD) is the leading cause of dementia, presenting a significant unmet medical need worldwide. The pathogenesis of…
Abstract Cannabis, the most consumed illicit psychoactive drug in the world, is increasingly used by pregnant women. However, while cannabinoid…
Abstract Cannabidiol (CBD) is a promising natural agent for treating psoriasis. CBD activity is attributed to inhibition of NF-kB, IL-1β,…